449 related articles for article (PubMed ID: 21076045)
61. The LIM-only protein LMO4 modulates the transcriptional activity of HEN1.
Manetopoulos C; Hansson A; Karlsson J; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Aug; 307(4):891-9. PubMed ID: 12878195
[TBL] [Abstract][Full Text] [Related]
62. LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.
Morishima T; Krahl AC; Nasri M; Xu Y; Aghaallaei N; Findik B; Klimiankou M; Ritter M; Hartmann MD; Gloeckner CJ; Stefanczyk S; Lindner C; Oswald B; Bernhard R; Hähnel K; Hermanutz-Klein U; Ebinger M; Handgretinger R; Casadei N; Welte K; Andre M; Müller P; Bajoghli B; Skokowa J
Blood; 2019 Oct; 134(14):1159-1175. PubMed ID: 31366618
[TBL] [Abstract][Full Text] [Related]
63. Structural basis for LMO2-driven recruitment of the SCL:E47bHLH heterodimer to hematopoietic-specific transcriptional targets.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Hall-Ponselé E; Platonova O; Vyas P; Patient R; Porcher C; Mancini EJ
Cell Rep; 2013 Jul; 4(1):135-47. PubMed ID: 23831025
[TBL] [Abstract][Full Text] [Related]
64. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
[TBL] [Abstract][Full Text] [Related]
65. A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts.
Vitelli L; Condorelli G; Lulli V; Hoang T; Luchetti L; Croce CM; Peschle C
Mol Cell Biol; 2000 Jul; 20(14):5330-42. PubMed ID: 10866689
[TBL] [Abstract][Full Text] [Related]
66. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
[TBL] [Abstract][Full Text] [Related]
67. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
68. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins.
Xu Z; Meng X; Cai Y; Liang H; Nagarajan L; Brandt SJ
Genes Dev; 2007 Apr; 21(8):942-55. PubMed ID: 17437998
[TBL] [Abstract][Full Text] [Related]
69. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
[TBL] [Abstract][Full Text] [Related]
70. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
71. Smad1 and Smad5 differentially regulate embryonic hematopoiesis.
McReynolds LJ; Gupta S; Figueroa ME; Mullins MC; Evans T
Blood; 2007 Dec; 110(12):3881-90. PubMed ID: 17761518
[TBL] [Abstract][Full Text] [Related]
72. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
73. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
[TBL] [Abstract][Full Text] [Related]
74. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.
Zhang M; Swanson PC
J Biol Chem; 2008 Mar; 283(11):6717-27. PubMed ID: 18187418
[TBL] [Abstract][Full Text] [Related]
75. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
76. A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2.
Wang Q; Zhang M; Wang X; Yuan W; Chen D; Royer-Pokora B; Zhu T
Leukemia; 2007 May; 21(5):1015-25. PubMed ID: 17361224
[TBL] [Abstract][Full Text] [Related]
77. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation.
Hansson A; Zetterblad J; van Duren C; Axelson H; Jönsson JI
Biochem Biophys Res Commun; 2007 Dec; 364(3):675-81. PubMed ID: 17964543
[TBL] [Abstract][Full Text] [Related]
78. T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2.
Mao S; Neale GA; Goorha RM
Oncogene; 1997 Apr; 14(13):1531-9. PubMed ID: 9129143
[TBL] [Abstract][Full Text] [Related]
79. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
[TBL] [Abstract][Full Text] [Related]
80. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]